Delivery Order SPE2DB20D3103-SPE2DB25FP2V7
Award Date 6/25/25
Potential Completion Date 6/26/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $13,021.65 and runs through March 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,090.78, is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty pharmaceutical product, with a ceiling value of $33,014.39 and a period of performance through June 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rebif Rebidose 44 mcg/0.5 ml prescription medication. The contract has a ceiling value of $6,200.73 and a performance period through December 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This is a $28,161.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. There is no set-aside designation noted for this contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract has a ceiling value of $5,010.98 and covers the delivery of Rebif 44 mcg/0.5 mL syringe 0.5 mL, a specialty medication. The contract is a firm-fixed-price delivery order with a completion date of March 13, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the government with REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. The Delivery Order has a ceiling value of $26,386.67 and a firm fixed price pricing...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,422.66, is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML medical products. The contract is a firm fixed-price delivery order with an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a multiple sclerosis medication. The contract has a firm fixed price of $12,729.15 and a completion date of July 11, 2025. This is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $21,032.26, is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The order is a firm fixed-price, delivery order type contract with a period of performance ending on September 9, 2024. Amerisourcebergen was awarded this contract without any set-aside designation, leveraging...